Key Points
Question
Is bariatric surgery cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis?
Findings
In this simulation model study, laparoscopic sleeve gastrectomy had an incremental cost-effectiveness ratio of $66 119 per quality-adjusted life-year in overweight patients, $18 716 per quality-adjusted life-year in patients with mild obesity, $10 274 per quality-adjusted life-year in patients with moderate obesity, and $6563 per quality-adjusted life-year in patients with severe obesity.
Meaning
Bariatric surgery could be highly cost-effective in patients with nonalcoholic steatohepatitis and compensated cirrhosis, even in those with a lower baseline body mass index.